Metabolic syndrome

被引：0
|
作者：
Cho, L. W. [1 ]
机构：
[1] Changi Gen Hosp, Dept Endocrinol, Singapore 529889, Singapore
来源：
SINGAPORE MEDICAL JOURNAL | 2011年 / 52卷 / 11期
关键词：
cardiometabolic risk; cardiovascular risk; insulin resistance syndrome; metabolic syndrome; OBSTRUCTIVE SLEEP-APNEA; POLYCYSTIC-OVARY-SYNDROME; CORONARY-HEART-DISEASE; FATTY LIVER-DISEASE; C-REACTIVE PROTEIN; INCIDENT CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE-SYNDROME; POSITIVE AIRWAY PRESSURE; RISK-FACTORS; DIABETES-MELLITUS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Metabolic syndrome is a clustering of different risk factors that collectively increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. The syndrome itself is associated with various metabolic abnormalities, including insulin resistance, non-alcoholic fatty liver disease, obstructive sleep apnoea, male hypogonadism and polycystic ovary syndrome. This review aims to discuss recent developments related to the syndrome, including the associated metabolic complications and goals for therapeutic strategies.
引用
收藏
页码：779 / 785
页数：7
相关论文
共 50 条
  • [21] The Metabolic Syndrome in Systemic Lupus Erythematosus
    Parker, Ben
    Bruce, Ian N.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (01) : 81 - +
  • [22] The Stability of Metabolic Syndrome in Children and Adolescents
    Gustafson, Jennifer K.
    Yanoff, Lisa B.
    Easter, Benjamin D.
    Brady, Sheila M.
    Keil, Margaret F.
    Roberts, Mary D.
    Sebring, Nancy G.
    Han, Joan C.
    Yanovski, Susan Z.
    Hubbard, Van S.
    Yanovski, Jack A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) : 4828 - 4834
  • [23] The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
    Rizzo, Manfredi
    Rizvi, Ali A.
    Rini, Giovam Battista
    Berneis, Kaspar
    ACTA DIABETOLOGICA, 2009, 46 (01) : 1 - 11
  • [24] The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis
    Kanwar, Pushpjeet
    Kowdley, Kris V.
    CLINICS IN LIVER DISEASE, 2016, 20 (02) : 225 - +
  • [25] Pharmacological treatment and therapeutic perspectives of metabolic syndrome
    Lim, Soo
    Eckel, Robert H.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (04) : 329 - 341
  • [26] Metabolic Syndrome, Mild Cognitive Impairment and Dementia
    Panza, F.
    Frisardi, V.
    Seripa, D.
    Imbimbo, B. P.
    Sancarlo, D.
    D'Onofrio, G.
    Addante, F.
    Paris, F.
    Pilotto, A.
    Solfrizzi, V.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (05) : 492 - 509
  • [27] Metabolic syndrome in older subjects: Coincidence or clustering?
    Bo, Mario
    Sona, Alessandro
    Astengo, Marco
    Fiandra, Umberto
    Quagliotti, Eleonora
    Brescianini, Alessia
    Fonte, Gianfranco
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 48 (02) : 146 - 150
  • [28] Link between Metabolic Syndrome and Insulin Resistance
    Gluvic, Zoran
    Zaric, Bozidarka
    Resanovic, Ivana
    Obradovic, Milan
    Mitrovic, Aleksandar
    Radak, Djordje
    Isenovic, Esma R.
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (01) : 30 - 39
  • [29] The Relationship between Psychosocial Stress, Age, BMI, CRP, Lifestyle, and the Metabolic Syndrome in Apparently Healthy Subjects
    Yamamoto, Kazuhiko
    Okazaki, Ai
    Ohmori, Susumu
    JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY, 2011, 30 (01) : 15 - 22
  • [30] Mechanisms and risk factors of metabolic syndrome in children and adolescents
    Codazzi, Valentina
    Frontino, Giulio
    Galimberti, Luca
    Giustina, Andrea
    Petrelli, Alessandra
    ENDOCRINE, 2024, 84 (01) : 16 - 28
12345